Skip to main content
. 2020 Sep 8;11:1340. doi: 10.3389/fphar.2020.01340

Table 3C.

Ligand interactions of the docked complexes with the least global energy of a category.

The name of the complex Residue active site Distance Bond category Type of H bond
1xbp and Napin (solution no. 7) 0:G1:H1 - 0:C2876:N3 1.58883 HB CHB
0:G1:H22 - 0:C2876:O2 1.38916 HB CHB
0:G2:H1 - 0:C2875:N3 1.97492 HB CHB
0:G2:H22 - 0:C2875:O2 1.43512 HB CHB
0:U3:H3 - 0:A2874:N1 1.50205 HB CHB
0:C4:H41 - 0:G2873:O6 2.94867 HB CHB
0:A5:H62 - 0:U2871:O4 2.9457 HB CHB
0:A5:H62 - 0:U2872:O4 2.48541 HB CHB
0:A6:H62 - 0:U2871:O4 2.42061 HB CHB
0:G7:H1 - 0:C2870:N3 1.64556 HB CHB
1xbp and procruciferin (solution no. 6) 0:G2044:HO2’ - 0:C2046:OP2 2.9279 HB CHB
0:G2044:H1 - 0:A2430:N1 3.09807 HB CHB
0:G2044:H22 -0:MUL2881:O4 1.52911 HB CHB
0:A2430:H62 - 0:G2044:O6 2.63632 HB CHB
0:A2482:HO2’ - 0:A2482:O3’ 1.76876 HB CHB
0:MUL2881:H1 - 0:A2482:N3 2.9486 HB CHB
0:G2044:H3’ - 0:G2044:OP2 2.75595 HB CaHB
0:G2044:H1’ - 0:A2482:N3 2.33872 HB CaHB
0:G2044:H8 - 0:A2482:O4’ 2.86672 HB CaHB
0:A2045:H8 - 0:A2045:O5’ 1.93278 HB CaHB
3FRA and napin (solution no. 3) A:LYS4:NZ - A:GLU8:OE2 5.04158 Elec AC
B:ARG11:NH1 - B:GLU12:OE2 5.06307 Elec AC
B:GLN6:HE22 - A:GLN1:OE1 2.31724 HB CHB
A:GLN6:HN - A:PRO2:O 2.41349 HB CHB
A:GLN6:HE21 - A:PRO2:O 3.01746 HB CHB
A:ARG7:HN - A:GLN3:O 1.64455 HB CHB
A:GLU8:HN - A:LYS4:O 1.55533 HB CHB
A:PHE9:HN - A:CYS5:O 1.92149 HB CHB
A:GLN10:HN - A:GLN6:O 2.24995 HB CHB
A:GLN10:HN - A:ARG7:O 2.43412 HB CHB
3FRA and Procruciferin (solution no. 7) X:THR1:HT2 – X:GLY87:O 2.3925 HB CHB
X:LEU2:HN – X:ASP106:OD2 1.62089 HB CHB
X:SER3:HN – X:VAL89:O 1.77077 HB CHB
X:SER3:HG – X:ASP107:OD2 1.58089 HB CHB
X:ILE4:HN – X:ASP107:O 1.99662 HB CHB
X:LEU5:HN – X:ILE91:O 1.76104 HB CHB
X:VAL6:HN – X:TYR109:O 2.05314 HB CHB
X:HIS8:HN – X:THR111:O 1.85144 HB CHB
X:HIS8:HD1 – X:ASP9:0 1.70772 HB CHB
X:ASP9:HN – X:VAL13:O 2.01965 HB CHB
3fyv and napin A:GLN1:HE22 - A:GLN3:OE1 2.92555 HB CHB
A:GLN6:HN - A:PRO2:O 2.44912 HB CHB
A:GLN6:HN - A:GLN3:O 2.95937 HB CHB
A:ARG7:HN - A:GLN3:O 1.64497 HB CHB
A:GLU8:HN - A:LYS4:O 1.72404 HB CHB
A:GLU8:HN - A:GLU8:OE1 2.77826 HB CHB
A:PHE9:HN - A:CYS5:O 1.85894 HB CHB
A:GLN10:HN - A:GLN6:O 2.24342 HB CHB
A:GLN10:HN - A:ARG7:O 2.32573 HB CHB
A:GLN11:HN - A:ARG7:O 1.73477 HB CHB
3fyv and procrucifrerin X:SER136:HG - A:THR86:O 3.0381 HB CHB
A:THR86:OG1 - X:GLU138:OE2 2.27006 HB CHB
B:ARG414:NH1 - X:LEU10:O 2.72974 HB CHB
X:SER136:HB2 - A:THR86:O 2.89323 HB CHB
X:THR1:HT2 - X:GLY87:O 2.30591 HB CHB
X:LEU2:HN - X:ASP106:OD2 1.86004 HB CHB
X:SER3:HN - X:VAL89:O 1.79673 HB CHB
X:SER3:HG - X:ASP107:OD2 1.62549 HB CHB
X:ILE4:HN - X:ASP107:O 2.0698 HB CHB
X:LEU5:HN - X:ILE91:O 1.78562 HB CHB
4urm and napin C:SER38:OG - D:GLU186:OE2 2.74016 HB CHB
C:SER40:OG - D:GLU186:OE1 2.76232 HB CHB
C:SER40:OG - D:GLU186:OE2 2.90773 HB CHB
D:SER40:HG - C:GLU186:OE2 3.03646 HB CHB
D:ARG42:HH22 - C:GLU186:O 1.6245 HB CHB
C:SER38:OG - D:GLU186:OE2 2.74016 HB CHB
C:SER40:OG - D:GLU186:OE1 2.76232 HB CHB
C:SER40:OG - D:GLU186:OE2 2.90773 HB CHB
D:ARG29:HH11 - D:ALA133:O 1.80548 HB CHB
D:LYS30:HN - D:GLU26:O 2.13732 HB CHB
4urm and procruciferin B:ILE183:HN - B:ASP180:O 2.37223 HB CHB
B:PHE184:HN - B:ASP180:O 1.85648 HB CHB
B:THR185:HN - B:ILE183:O 2.37084 HB CHB
B:THR187:HG1 - B:VAL189:O 2.97098 HB CHB
B:TYR190:HN - B:ASN75:OD1 2.23923 HB CHB
B:ASN191:HN - B:HIS45:NE2 1.84241 HB CHB
B:TYR192:HH - B:ASP225:OD1 2.1739 HB CHB
B:GLU193:HN - B:ASN191:OD1 2.81969 HB CHB
B:THR194:HN - B:ASN191:O 2.67423 HB CHB
B:THR194:HN - B:ASN191:OD1 2.43501 HB CHB